| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679931 | Alzheimer's & Dementia | 2018 | 13 Pages |
Abstract
With M1/sigma-1 activity and long-lasting disease-modifying properties at low dose, AF710B is a promising novel therapeutic agent for treating Alzheimer's disease.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Hélène Hall, Maria Florencia Iulita, Palma Gubert, Lisi Flores Aguilar, Adriana Ducatenzeiler, Abraham Fisher, Augusto Claudio Cuello,